BIOSPECIFICS TECHNOLOGIES CORP·4

Sep 4, 8:48 PM ET

BIOSPECIFICS TECHNOLOGIES CORP 4

4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Sep 4, 2013

Insider Transaction Report

Form 4
Period: 2013-08-30
Morgan Henry
Director
Transactions
  • Sale

    Common Stock, $0.001 par value

    2013-09-03$18.38/sh1,204$22,13335,043 total
  • Sale

    Common Stock, $0.001 par value

    2013-08-30$18.30/sh946$17,31236,247 total
Footnotes (2)
  • [F1]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $18.30 to $18.30. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F2]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $18.35 to $18.45. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES